Skip to main content

. 1977 Aug;4(4):499–500. doi: 10.1111/j.1365-2125.1977.tb00775.x

beta-Adrenoceptor blocking agents and human fat cell adenylate cyclase.

H Kather, B Simon

PMCID: PMC1429056 PMID: 20125

499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bengtsson C. Comparison between alprenolol and chlorthalidone as antihypertensive agents. Acta Med Scand. 1972 May;191(5):433–439. [PubMed] [Google Scholar]
Holland O. B., Kaplan N. M. Propranolol in the treatment of hypertension. N Engl J Med. 1976 Apr 22;294(17):930–936. doi: 10.1056/NEJM197604222941706. [DOI] [PubMed] [Google Scholar]
Kather H., Simon B. Catecholamine-sensitive adenylate cyclase of human fat cell ghosts. Characteristics of the GMP(PNP)-liganded state. Clin Chim Acta. 1976 Dec;73(3):497–504. doi: 10.1016/0009-8981(76)90153-4. [DOI] [PubMed] [Google Scholar]
Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
Shand D. G. Drug therapy: Propranolol. N Engl J Med. 1975 Aug 7;293(6):280–285. doi: 10.1056/NEJM197508072930606. [DOI] [PubMed] [Google Scholar]
Simpson F. O. Beta-adrenergic receptor blocking drugs in hypertension. Drugs. 1974;7(1):85–105. doi: 10.2165/00003495-197407010-00006. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES